Pharming (PHAR) Other Gross PP&E Adjustments (2019 - 2025)
Historic Other Gross PP&E Adjustments for Pharming (PHAR) over the last 7 years, with Q3 2025 value amounting to -$17.5 million.
- Pharming's Other Gross PP&E Adjustments rose 2028.67% to -$17.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$17.5 million, marking a year-over-year increase of 2028.67%. This contributed to the annual value of -$16.4 million for FY2024, which is 3110.15% up from last year.
- Per Pharming's latest filing, its Other Gross PP&E Adjustments stood at -$17.5 million for Q3 2025, which was up 2028.67% from -$16.6 million recorded in Q2 2025.
- In the past 5 years, Pharming's Other Gross PP&E Adjustments registered a high of -$9067.3 during Q1 2021, and its lowest value of -$30.4 million during Q1 2023.
- Moreover, its 5-year median value for Other Gross PP&E Adjustments was -$21.3 million (2021), whereas its average is -$18.7 million.
- Data for Pharming's Other Gross PP&E Adjustments shows a peak YoY increase of 9992.04% (in 2022) and a maximum YoY decrease of 21420911.44% (in 2022) over the last 5 years.
- Pharming's Other Gross PP&E Adjustments (Quarter) stood at -$20129.3 in 2021, then tumbled by 142741.42% to -$28.8 million in 2022, then rose by 17.31% to -$23.8 million in 2023, then skyrocketed by 31.1% to -$16.4 million in 2024, then fell by 6.93% to -$17.5 million in 2025.
- Its Other Gross PP&E Adjustments stands at -$17.5 million for Q3 2025, versus -$16.6 million for Q2 2025 and -$16.5 million for Q1 2025.